Novo Nordisk - Профиль
Novo Nordisk A/S is a healthcare company, which engages in the research, development, manufacture, and marketing of pharmaceutical products. It operates through the following segments: Diabetes & Obesity Care, and Biopharmaceuticals. The Diabetes & Obesity Care segment covers products for insulin; GLP-1 and related delivery systems; oral antidiabetic products; and obesity. The Biopharmaceuticals segment offers products for haemophilia; growth hormone therapy; and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in BagsvÃ¦rd, Denmark.
|Novo Nordisk Fonden||7,29|
|Government Pension Fund - Global (The)||2,29|
|Vanguard Total International Stock Index Fund||1,42|
|Fundsmith Equity Fund||0,95|
|Vanguard Developed Markets Index Fund||0,57|